Theravance Biopharma, Inc. (Nasdaq: TBPH) announced that it intends to commence concurrent underwritten public offerings, subject to market and other ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE